Ultrasonic tissue-type imaging (TTI) for planning treatment of prostate cancer

Ernest Joseph Feleppa; Jeffrey A. Ketterling; Christopher R. Porter; John Gillespie; Cheng-Shie Wuu; Stella Urban; Andrew Kalisz; Ronald D. Ennis; Peter Bernhard Schiff

doi:10.1117/12.543632

28 April 2004 Ultrasonic tissue-type imaging (TTI) for planning treatment of prostate cancer

Ernest Joseph Feleppa, Jeffrey A. Ketterling, Christopher R. Porter, John Gillespie, Cheng-Shie Wuu, Stella Urban, Andrew Kalisz, Ronald D. Ennis, Peter Bernhard Schiff

Author Affiliations +

Proceedings Volume 5373, Medical Imaging 2004: Ultrasonic Imaging and Signal Processing; (2004) https://doi.org/10.1117/12.543632
Event: Medical Imaging 2004, 2004, San Diego, California, United States

Abstract

Our research is intended to develop ultrasonic methods for characterizing cancerous prostate tissue and thereby to improve the effectiveness of biopsy guidance, therapy targeting, and treatment monitoring. We acquired radio-frequency (RF) echo-signal data and clinical variables, e.g., PSA, during biopsy examinations. We computed spectra of the RF signals in each biopsied region, and trained neural network classifers with over 3,000 sets of data using biopsy data as the gold standard. For imaging, a lookup table returned scores for cancer likelihood on a pixel-by-pixel basis from spectral-parameter and PSA values. Using ROC analyses, we compared classification performance of artificial neural networks (ANNs) to conventional classification with a leave-one-patient-out approach intended to minimize the chance of bias. Tissue-type images (TTIs) were compared to prostatectomy histology to further assess classification performance. ROC-curve areas were greater for ANNs than for the B-mode-based classification by more than 20%, e.g., 0.75 +/- 0.03 for neural-networks vs. 0.64 +/- 0.03 for B-mode LOSs. ANN sensitivity was 17% better than the sensitivity range of ultrasound-guided biopsies. TTIs showed tumors that were entirely unrecognized in conventional images and undetected during surgery. We are investigating TTIs for guiding prostrate biopsies, and for planning radiation dose-escalation and tissue-sparing options, and monitoring prostrate cancer.

Citation Download Citation

Ernest Joseph Feleppa, Jeffrey A. Ketterling, Christopher R. Porter, John Gillespie, Cheng-Shie Wuu, Stella Urban, Andrew Kalisz, Ronald D. Ennis, and Peter Bernhard Schiff "Ultrasonic tissue-type imaging (TTI) for planning treatment of prostate cancer", Proc. SPIE 5373, Medical Imaging 2004: Ultrasonic Imaging and Signal Processing, (28 April 2004); https://doi.org/10.1117/12.543632

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available